These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18158982)

  • 1. The oncology acute toxicity unit (OATU): an outpatient facility for improving the management of chemotherapy toxicity.
    Majem M; Galán M; Pérez FJ; Muñoz M; Chicote S; Soler G; Navarro M; Martínez-Villacampa M; García del Muro X; Dotor E; Laquente B; Germà JR
    Clin Transl Oncol; 2007 Dec; 9(12):784-8. PubMed ID: 18158982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study to assess the pharmacy impact of implementing a chemotherapy-induced nausea or vomiting collaborative disease therapy management in the outpatient oncology clinics.
    Jackson K; Letton C; Maldonado A; Bodiford A; Sion A; Hartwell R; Graham A; Bondarenka C; Uber L
    J Oncol Pharm Pract; 2019 Jun; 25(4):847-854. PubMed ID: 29587608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital management of outpatient oncology treatment decisions: a survey to identify strategies and concerns.
    Li E; Schleif R; Edelen B
    J Oncol Pract; 2013 Sep; 9(5):e248-54. PubMed ID: 23943887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nurse-led evidence-based practice project to monitor and improve the management of chemotherapy-induced nausea and vomiting.
    Underhill ML; Chicko L; Berry DL
    Clin J Oncol Nurs; 2015 Feb; 19(1):38-40. PubMed ID: 25689647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility, caller, and patient profile of a novel Chemotherapy Telephone Helpline service within a regional cancer centre in Northern Ireland.
    Reid J; Porter S
    Cancer Nurs; 2011; 34(3):E27-32. PubMed ID: 21512342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacists contribute to the improved efficiency of medical practices in the outpatient cancer chemotherapy clinic.
    Iihara H; Ishihara M; Matsuura K; Kurahashi S; Takahashi T; Kawaguchi Y; Yoshida K; Itoh Y
    J Eval Clin Pract; 2012 Aug; 18(4):753-60. PubMed ID: 21414113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palonosetron versus other 5-HT(3) receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with cancer on chemotherapy in a hospital outpatient setting.
    Balu S; Buchner D; Craver C; Gayle J
    Clin Ther; 2011 Apr; 33(4):443-55. PubMed ID: 21635990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Securing patients pathways treated by oral antitumoral: Guidelines for better organization of departments and management of incoming calls].
    Fléchon A; Villeminey C; Despiau F; Bertrand C; Lecarpentier E; Joly F
    Bull Cancer; 2019 Jun; 106(6):514-526. PubMed ID: 31126678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nursing intervention to enhance outpatient chemotherapy symptom management: Patient-reported outcomes of a randomized controlled trial.
    Traeger L; McDonnell TM; McCarty CE; Greer JA; El-Jawahri A; Temel JS
    Cancer; 2015 Nov; 121(21):3905-13. PubMed ID: 26194461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center.
    Aseeri M; Mukhtar A; Al Khansa S; Elimam N; Jastaniah W
    J Oncol Pharm Pract; 2013 Jun; 19(2):138-44. PubMed ID: 23034405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of adverse events and survival in colorectal cancer patients treated with adjuvant 5-fluorouracil and leucovorin: Is efficacy an impact of toxicity?
    Soveri LM; Hermunen K; de Gramont A; Poussa T; Quinaux E; Bono P; André T; Österlund P
    Eur J Cancer; 2014 Nov; 50(17):2966-74. PubMed ID: 25266443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A telephone call reminder to improve outpatient attendance in patients referred from the emergency department: a randomised controlled trial.
    Ritchie PD; Jenkins M; Cameron PA
    Aust N Z J Med; 2000 Oct; 30(5):585-92. PubMed ID: 11108069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of adverse events via a telephone consultation service for cancer patients receiving ambulatory chemotherapy.
    Kondo S; Shiba S; Udagawa R; Ryushima Y; Yano M; Uehara T; Asanabe M; Tamura K; Hashimoto J
    BMC Res Notes; 2015 Jul; 8():315. PubMed ID: 26210162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ten most common adverse drug reactions (ADRs) in oncology patients: do they matter to you?
    Lau PM; Stewart K; Dooley M
    Support Care Cancer; 2004 Sep; 12(9):626-33. PubMed ID: 15064936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy-induced nausea and vomiting: incidence and characteristics of persistent symptoms and future directions NCCTG N08C3 (Alliance).
    Kottschade L; Novotny P; Lyss A; Mazurczak M; Loprinzi C; Barton D
    Support Care Cancer; 2016 Jun; 24(6):2661-7. PubMed ID: 26768436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a contact center telephone helpline in rheumatology outpatient management: a five-year experience analysis and patients' perception.
    Scrivo R; Priori R; Coppola M; Minniti A; Brandt J; Picarelli G; Cruciani V; Luzi P; Valesini G
    Mod Rheumatol; 2014 Jul; 24(4):585-9. PubMed ID: 24252008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life consequences of chemotherapy-induced emesis.
    Lindley CM; Hirsch JD; O'Neill CV; Transau MC; Gilbert CS; Osterhaus JT
    Qual Life Res; 1992 Oct; 1(5):331-40. PubMed ID: 1299465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palonosetron versus other 5-HT₃ receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with hematologic malignancies treated with emetogenic chemotherapy in a hospital outpatient setting in the United States.
    Craver C; Gayle J; Balu S; Buchner D
    J Med Econ; 2011; 14(3):341-9. PubMed ID: 21542674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The differences in the assessments of side effects at an oncology outpatient clinic.
    Bayraktar-Ekincioglu A; Kucuk E
    Int J Clin Pharm; 2018 Apr; 40(2):386-393. PubMed ID: 29353396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common toxicities of cancer chemotherapy.
    Khoo KS; Ang PT; Lim AG
    Singapore Med J; 1993 Oct; 34(5):418-20. PubMed ID: 8153689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.